Form 4 for CCEL CRYO CELL INTERNATIONAL INC
Accepted 2025-09-18 00:00:00 ET · period of report 2025-09-16 · accession 0001193125-25-207528 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-09-18 | 2025-09-16+ | CCEL | PORTNOY DAVID | COB, Co-CEO, Dir, 10% | P - Purchase | $4.45 | +15.4K | 823.9K | +2% | +$68.6K |
| I | 2025-09-18 | 2025-09-18 | CCEL | PORTNOY DAVID | COB, Co-CEO, Dir, 10% | P - Purchase | $4.49 | +1,751 | 161.8K | +1% | +$7,862 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-16 | P | A | 6,449 | $4.46 | 818,369 | D By Corporation | — | — | (F1) The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.40 to $4.47, inclusive. The reporting person undertakes to provide to Cryo-Cell International, Inc. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. (F4) Shares of Common Stock held by PartnerCommunity, Inc., as to which David I. Portnoy may be deemed beneficial owner as the Chairman of the Board and Secretary. |
| 2 | Common | Common Stock | 2025-09-18 | P | A | 1,751 | $4.49 | 161,833 | I | — | — | |
| 3 | Common | Common Stock | 2025-09-18 | P | A | 3,411 | $4.46 | 827,344 | D | — | — | (F3) The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.45 to $4.50, inclusive. The reporting person undertakes to provide to Cryo-Cell International, Inc. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
| 4 | Common | Common Stock | 2025-09-17 | P | A | 5,564 | $4.43 | 823,933 | D | — | — | (F2) The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.41 to $4.45, inclusive. The reporting person undertakes to provide to Cryo-Cell International, Inc. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |